Share Price and Basic Stock Data
Last Updated: January 16, 2026, 11:47 am
| PEG Ratio | 0.56 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Refex Industries Ltd operates within the industrial gases sector, a field characterized by its critical role in various industries including manufacturing and healthcare. The company reported a market capitalization of ₹3,243 Cr and a share price of ₹237. In terms of revenue, Refex showed significant growth, with sales rising from ₹444 Cr in FY 2022 to ₹1,629 Cr in FY 2023, reflecting a robust increase in demand for its products. The trailing twelve months (TTM) revenue stood at ₹2,108 Cr, indicating a healthy upward trajectory. The quarterly sales also displayed variability; for instance, sales peaked at ₹630 Cr in March 2023 but subsequently decreased to ₹350 Cr in September 2023, highlighting potential seasonality or operational challenges. Overall, the revenue growth trajectory over the past years positions Refex favorably within an expanding market.
Profitability and Efficiency Metrics
Refex Industries has demonstrated solid profitability metrics, with a reported net profit of ₹201 Cr, translating to a net profit margin of 6.41% for FY 2025. The operating profit margin (OPM) stood at 10.54%, slightly below the typical sector range but indicative of effective cost management. The company recorded a return on equity (ROE) of 22.0% and a return on capital employed (ROCE) of 25.3%, both of which are favorable compared to industry averages, suggesting efficient capital utilization. Additionally, the interest coverage ratio (ICR) was a strong 9.39x, indicating that the company comfortably meets its interest obligations. However, fluctuations in OPM over quarters, with a notable decline to 8% in December 2024, may raise concerns regarding operational consistency.
Balance Sheet Strength and Financial Ratios
Refex’s balance sheet reflects stability and a sound financial position, with total borrowings amounting to ₹165 Cr against reserves of ₹1,311 Cr as of September 2025. The debt-to-equity ratio stood at 0.16, indicating a low reliance on debt financing, which is favorable in the current economic climate. The current ratio of 3.49 and quick ratio of 3.47 suggest strong liquidity, enabling the company to cover its short-term liabilities effectively. Furthermore, the price-to-book value (P/BV) ratio is at 4.61x, which, while on the higher side, indicates market confidence in the company’s growth prospects. The efficiency metrics, such as cash conversion cycle (CCC) at 66 days, are reasonable, although there is room for improvement compared to sector norms.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Refex Industries indicates a significant promoter stake of 55.92%, which enhances stability and aligns interests with shareholders. Foreign institutional investors (FIIs) hold 1.60%, while domestic institutional investors (DIIs) have a minimal presence of 0.14%. The public shareholding is substantial at 42.34%, involving approximately 89,600 shareholders. Over the past year, promoter holdings have shown a gradual increase, suggesting a commitment to the company’s long-term strategy. However, the low institutional investment could reflect cautious sentiment among larger investors. The growing number of shareholders indicates increasing retail interest, which may enhance liquidity and marketability of the shares.
Outlook, Risks, and Final Insight
Looking ahead, Refex Industries is poised for growth driven by increasing demand in the industrial gases sector. However, the company must navigate several risks, including potential volatility in raw material prices and operational challenges that may affect profitability. The fluctuating sales figures, particularly the decline in quarterly revenues, pose a concern for maintaining consistent growth. Additionally, while the company’s low debt levels are a strength, any adverse economic conditions could impact its operational efficiency. In conclusion, Refex Industries presents a compelling investment opportunity, contingent on its ability to sustain revenue growth and manage operational risks effectively. Investors should monitor quarterly performance closely, as consistent operational results will be crucial for long-term value creation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gagan Gases Ltd | 9.90 Cr. | 21.9 | 35.8/17.6 | 82.5 | 7.17 | 0.00 % | 10.6 % | 8.49 % | 10.0 |
| Bhagawati Oxygen Ltd | 9.27 Cr. | 40.1 | 67.0/36.3 | 927 | 17.5 | 0.00 % | 6.68 % | 10.6 % | 10.0 |
| Refex Industries Ltd | 3,303 Cr. | 241 | 534/212 | 16.4 | 103 | 0.21 % | 25.3 % | 22.0 % | 2.00 |
| Linde India Ltd | 51,850 Cr. | 6,080 | 7,870/5,202 | 102 | 463 | 0.07 % | 16.9 % | 12.3 % | 10.0 |
| Industry Average | 27,576.50 Cr | 1,595.75 | 281.98 | 147.67 | 0.07% | 14.87% | 13.35% | 8.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 353 | 380 | 630 | 381 | 350 | 302 | 337 | 585 | 428 | 708 | 611 | 365 | 423 |
| Expenses | 317 | 341 | 557 | 345 | 315 | 268 | 294 | 533 | 385 | 655 | 548 | 325 | 349 |
| Operating Profit | 37 | 40 | 74 | 37 | 35 | 34 | 44 | 52 | 43 | 53 | 64 | 40 | 74 |
| OPM % | 10% | 10% | 12% | 10% | 10% | 11% | 13% | 9% | 10% | 8% | 10% | 11% | 17% |
| Other Income | 2 | 1 | 2 | 2 | 5 | 3 | 8 | 2 | 12 | 25 | 16 | 11 | 8 |
| Interest | 3 | 4 | 6 | 6 | 6 | 7 | 7 | 4 | 4 | 5 | 5 | 6 | 6 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 |
| Profit before tax | 34 | 36 | 68 | 30 | 32 | 27 | 43 | 48 | 49 | 71 | 72 | 41 | 71 |
| Tax % | 26% | 26% | 25% | 26% | 27% | 28% | 16% | 25% | 23% | 17% | 21% | 20% | 27% |
| Net Profit | 25 | 26 | 51 | 22 | 23 | 20 | 36 | 36 | 37 | 59 | 57 | 33 | 52 |
| EPS in Rs | 2.42 | 2.37 | 4.59 | 1.99 | 2.12 | 1.79 | 3.09 | 3.11 | 3.09 | 4.58 | 4.42 | 2.55 | 4.02 |
Last Updated: December 29, 2025, 9:16 am
Below is a detailed analysis of the quarterly data for Refex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 423.00 Cr.. The value appears strong and on an upward trend. It has increased from 365.00 Cr. (Jun 2025) to 423.00 Cr., marking an increase of 58.00 Cr..
- For Expenses, as of Sep 2025, the value is 349.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 325.00 Cr. (Jun 2025) to 349.00 Cr., marking an increase of 24.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Jun 2025) to 74.00 Cr., marking an increase of 34.00 Cr..
- For OPM %, as of Sep 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Jun 2025) to 17.00%, marking an increase of 6.00%.
- For Other Income, as of Sep 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Jun 2025) to 8.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 6.00 Cr..
- For Depreciation, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 71.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Jun 2025) to 71.00 Cr., marking an increase of 30.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Jun 2025) to 27.00%, marking an increase of 7.00%.
- For Net Profit, as of Sep 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Jun 2025) to 52.00 Cr., marking an increase of 19.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.02. The value appears strong and on an upward trend. It has increased from 2.55 (Jun 2025) to 4.02, marking an increase of 1.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25 | 85 | 78 | 38 | 77 | 461 | 661 | 633 | 444 | 1,629 | 1,371 | 2,430 | 2,108 |
| Expenses | 22 | 79 | 75 | 36 | 75 | 433 | 609 | 565 | 383 | 1,454 | 1,222 | 2,214 | 1,877 |
| Operating Profit | 2 | 6 | 3 | 2 | 2 | 28 | 51 | 68 | 61 | 175 | 149 | 216 | 231 |
| OPM % | 10% | 7% | 3% | 6% | 2% | 6% | 8% | 11% | 14% | 11% | 11% | 9% | 11% |
| Other Income | 3 | 0 | 0 | 2 | 2 | 2 | -1 | 4 | 18 | 8 | 18 | 52 | 61 |
| Interest | 2 | 0 | 1 | 3 | 1 | 0 | 1 | 9 | 13 | 19 | 26 | 18 | 22 |
| Depreciation | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 5 | 6 | 7 | 9 | 11 | 14 |
| Profit before tax | 1 | 3 | 0 | 1 | 2 | 29 | 48 | 58 | 61 | 156 | 132 | 241 | 256 |
| Tax % | 0% | 0% | -1,613% | 13% | 46% | -10% | 31% | 29% | 26% | 26% | 23% | 21% | |
| Net Profit | 1 | 3 | 5 | 0 | 1 | 32 | 33 | 41 | 45 | 116 | 101 | 189 | 201 |
| EPS in Rs | 0.11 | 0.29 | 0.51 | 0.04 | 0.09 | 3.01 | 3.16 | 3.90 | 4.32 | 10.50 | 8.73 | 14.66 | 15.57 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 8% | 0% | 4% | 6% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | 66.67% | -100.00% | 3100.00% | 3.12% | 24.24% | 9.76% | 157.78% | -12.93% | 87.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | -133.33% | -166.67% | 3200.00% | -3096.88% | 21.12% | -14.49% | 148.02% | -170.71% | 100.06% |
Refex Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 30% |
| 3 Years: | 76% |
| TTM: | 40% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 51% |
| 5 Years: | 39% |
| 3 Years: | 75% |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 72% |
| 5 Years: | 109% |
| 3 Years: | 133% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 27% |
| 3 Years: | 27% |
| Last Year: | 22% |
Last Updated: September 5, 2025, 1:00 pm
Balance Sheet
Last Updated: January 7, 2026, 4:18 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 21 | 21 | 22 | 23 | 26 | 26 |
| Reserves | -14 | -11 | -6 | -5 | -4 | 27 | 60 | 119 | 163 | 292 | 450 | 1,224 | 1,311 |
| Borrowings | 11 | 9 | 37 | 35 | 41 | 0 | 9 | 74 | 85 | 149 | 161 | 158 | 165 |
| Other Liabilities | 23 | 56 | 71 | 15 | 45 | 115 | 53 | 128 | 112 | 288 | 114 | 272 | 292 |
| Total Liabilities | 35 | 70 | 118 | 60 | 98 | 159 | 138 | 341 | 381 | 752 | 748 | 1,681 | 1,793 |
| Fixed Assets | 17 | 16 | 15 | 15 | 14 | 15 | 22 | 87 | 85 | 147 | 144 | 199 | 191 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 9 | 6 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 74 | 74 | 81 | 114 | 145 |
| Other Assets | 17 | 54 | 103 | 45 | 83 | 143 | 116 | 181 | 222 | 528 | 514 | 1,362 | 1,449 |
| Total Assets | 35 | 70 | 118 | 60 | 98 | 159 | 138 | 341 | 381 | 752 | 748 | 1,681 | 1,793 |
Below is a detailed analysis of the balance sheet data for Refex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,311.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,224.00 Cr. (Mar 2025) to 1,311.00 Cr., marking an increase of 87.00 Cr..
- For Borrowings, as of Sep 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 158.00 Cr. (Mar 2025) to 165.00 Cr., marking an increase of 7.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 292.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 272.00 Cr. (Mar 2025) to 292.00 Cr., marking an increase of 20.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,793.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,681.00 Cr. (Mar 2025) to 1,793.00 Cr., marking an increase of 112.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 191.00 Cr.. The value appears to be declining and may need further review. It has decreased from 199.00 Cr. (Mar 2025) to 191.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 145.00 Cr.. The value appears strong and on an upward trend. It has increased from 114.00 Cr. (Mar 2025) to 145.00 Cr., marking an increase of 31.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,449.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,362.00 Cr. (Mar 2025) to 1,449.00 Cr., marking an increase of 87.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,793.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,681.00 Cr. (Mar 2025) to 1,793.00 Cr., marking an increase of 112.00 Cr..
Notably, the Reserves (1,311.00 Cr.) exceed the Borrowings (165.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -9.00 | -3.00 | -34.00 | -33.00 | -39.00 | 28.00 | 42.00 | -6.00 | -24.00 | 26.00 | -12.00 | 58.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 65 | 215 | 376 | 87 | 173 | 69 | 40 | 54 | 96 | 55 | 81 | 101 |
| Inventory Days | 174 | 4 | 7 | 22 | 33 | 7 | 2 | 4 | 8 | 3 | 3 | 2 |
| Days Payable | 321 | 281 | 382 | 156 | 264 | 92 | 27 | 70 | 79 | 49 | 21 | 37 |
| Cash Conversion Cycle | -82 | -63 | 1 | -47 | -57 | -15 | 15 | -12 | 24 | 8 | 63 | 66 |
| Working Capital Days | -273 | -34 | -40 | 255 | 159 | 9 | 20 | 14 | 70 | 41 | 74 | 99 |
| ROCE % | 15% | 24% | 6% | 7% | 6% | 61% | 85% | 45% | 25% | 48% | 29% | 25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.93 | 8.40 | 53.89 | 21.73 | 21.37 |
| Diluted EPS (Rs.) | 12.38 | 8.36 | 53.84 | 21.73 | 21.37 |
| Cash EPS (Rs.) | 14.78 | 9.21 | 55.62 | 22.01 | 22.31 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 81.93 | 40.25 | 142.21 | 66.45 | 48.98 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 81.93 | 40.25 | 142.21 | 66.45 | 48.98 |
| Revenue From Operations / Share (Rs.) | 191.02 | 119.54 | 736.94 | 301.24 | 426.97 |
| PBDIT / Share (Rs.) | 20.14 | 14.21 | 82.75 | 34.34 | 36.27 |
| PBIT / Share (Rs.) | 17.62 | 13.04 | 79.63 | 31.82 | 35.37 |
| PBT / Share (Rs.) | 15.48 | 10.49 | 70.74 | 27.55 | 31.03 |
| Net Profit / Share (Rs.) | 12.26 | 8.04 | 52.50 | 19.49 | 21.41 |
| NP After MI And SOA / Share (Rs.) | 12.29 | 8.11 | 52.50 | 19.49 | 21.41 |
| PBDIT Margin (%) | 10.54 | 11.88 | 11.22 | 11.39 | 8.49 |
| PBIT Margin (%) | 9.22 | 10.90 | 10.80 | 10.56 | 8.28 |
| PBT Margin (%) | 8.10 | 8.77 | 9.59 | 9.14 | 7.26 |
| Net Profit Margin (%) | 6.41 | 6.72 | 7.12 | 6.47 | 5.01 |
| NP After MI And SOA Margin (%) | 6.43 | 6.78 | 7.12 | 6.47 | 5.01 |
| Return on Networth / Equity (%) | 15.00 | 20.16 | 36.91 | 29.33 | 43.70 |
| Return on Capital Employeed (%) | 16.22 | 24.96 | 41.88 | 31.47 | 61.36 |
| Return On Assets (%) | 8.82 | 11.76 | 15.42 | 11.99 | 24.01 |
| Long Term Debt / Equity (X) | 0.08 | 0.11 | 0.12 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.16 | 0.25 | 0.26 | 0.00 | 0.02 |
| Asset Turnover Ratio (%) | 1.90 | 1.78 | 0.00 | 2.64 | 4.46 |
| Current Ratio (X) | 3.49 | 2.59 | 1.59 | 1.32 | 2.24 |
| Quick Ratio (X) | 3.47 | 2.55 | 1.55 | 1.28 | 2.18 |
| Inventory Turnover Ratio (X) | 336.97 | 153.27 | 0.00 | 47.60 | 80.69 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 5.88 | 0.00 | 5.13 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 5.14 | 0.00 | 4.54 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 94.12 | 0.00 | 94.87 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 94.86 | 0.00 | 95.46 | 0.00 |
| Interest Coverage Ratio (X) | 9.39 | 5.60 | 9.42 | 8.04 | 61.97 |
| Interest Coverage Ratio (Post Tax) (X) | 6.72 | 4.17 | 6.99 | 5.56 | 43.99 |
| Enterprise Value (Cr.) | 4698.88 | 1642.00 | 596.42 | 180.07 | 32.99 |
| EV / Net Operating Revenue (X) | 1.90 | 1.19 | 0.36 | 0.28 | 0.04 |
| EV / EBITDA (X) | 18.06 | 9.99 | 3.26 | 2.50 | 0.58 |
| MarketCap / Net Operating Revenue (X) | 1.98 | 1.13 | 0.32 | 0.31 | 0.07 |
| Retention Ratios (%) | 0.00 | 94.11 | 0.00 | 94.86 | 0.00 |
| Price / BV (X) | 4.61 | 3.35 | 1.67 | 1.41 | 0.68 |
| Price / Net Operating Revenue (X) | 1.98 | 1.13 | 0.32 | 0.31 | 0.07 |
| EarningsYield | 0.03 | 0.06 | 0.22 | 0.20 | 0.63 |
After reviewing the key financial ratios for Refex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.93. This value is within the healthy range. It has increased from 8.40 (Mar 24) to 12.93, marking an increase of 4.53.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.38. This value is within the healthy range. It has increased from 8.36 (Mar 24) to 12.38, marking an increase of 4.02.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.78. This value is within the healthy range. It has increased from 9.21 (Mar 24) to 14.78, marking an increase of 5.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.93. It has increased from 40.25 (Mar 24) to 81.93, marking an increase of 41.68.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.93. It has increased from 40.25 (Mar 24) to 81.93, marking an increase of 41.68.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 191.02. It has increased from 119.54 (Mar 24) to 191.02, marking an increase of 71.48.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 20.14. This value is within the healthy range. It has increased from 14.21 (Mar 24) to 20.14, marking an increase of 5.93.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.62. This value is within the healthy range. It has increased from 13.04 (Mar 24) to 17.62, marking an increase of 4.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.48. This value is within the healthy range. It has increased from 10.49 (Mar 24) to 15.48, marking an increase of 4.99.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.26. This value is within the healthy range. It has increased from 8.04 (Mar 24) to 12.26, marking an increase of 4.22.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.29. This value is within the healthy range. It has increased from 8.11 (Mar 24) to 12.29, marking an increase of 4.18.
- For PBDIT Margin (%), as of Mar 25, the value is 10.54. This value is within the healthy range. It has decreased from 11.88 (Mar 24) to 10.54, marking a decrease of 1.34.
- For PBIT Margin (%), as of Mar 25, the value is 9.22. This value is below the healthy minimum of 10. It has decreased from 10.90 (Mar 24) to 9.22, marking a decrease of 1.68.
- For PBT Margin (%), as of Mar 25, the value is 8.10. This value is below the healthy minimum of 10. It has decreased from 8.77 (Mar 24) to 8.10, marking a decrease of 0.67.
- For Net Profit Margin (%), as of Mar 25, the value is 6.41. This value is within the healthy range. It has decreased from 6.72 (Mar 24) to 6.41, marking a decrease of 0.31.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.43. This value is below the healthy minimum of 8. It has decreased from 6.78 (Mar 24) to 6.43, marking a decrease of 0.35.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.00. This value is within the healthy range. It has decreased from 20.16 (Mar 24) to 15.00, marking a decrease of 5.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.22. This value is within the healthy range. It has decreased from 24.96 (Mar 24) to 16.22, marking a decrease of 8.74.
- For Return On Assets (%), as of Mar 25, the value is 8.82. This value is within the healthy range. It has decreased from 11.76 (Mar 24) to 8.82, marking a decrease of 2.94.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.11 (Mar 24) to 0.08, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.25 (Mar 24) to 0.16, marking a decrease of 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.90. It has increased from 1.78 (Mar 24) to 1.90, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 3.49. This value exceeds the healthy maximum of 3. It has increased from 2.59 (Mar 24) to 3.49, marking an increase of 0.90.
- For Quick Ratio (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 2. It has increased from 2.55 (Mar 24) to 3.47, marking an increase of 0.92.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 336.97. This value exceeds the healthy maximum of 8. It has increased from 153.27 (Mar 24) to 336.97, marking an increase of 183.70.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.88 (Mar 24) to 0.00, marking a decrease of 5.88.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.14 (Mar 24) to 0.00, marking a decrease of 5.14.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.12 (Mar 24) to 0.00, marking a decrease of 94.12.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.86 (Mar 24) to 0.00, marking a decrease of 94.86.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.39. This value is within the healthy range. It has increased from 5.60 (Mar 24) to 9.39, marking an increase of 3.79.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.72. This value is within the healthy range. It has increased from 4.17 (Mar 24) to 6.72, marking an increase of 2.55.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,698.88. It has increased from 1,642.00 (Mar 24) to 4,698.88, marking an increase of 3,056.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has increased from 1.19 (Mar 24) to 1.90, marking an increase of 0.71.
- For EV / EBITDA (X), as of Mar 25, the value is 18.06. This value exceeds the healthy maximum of 15. It has increased from 9.99 (Mar 24) to 18.06, marking an increase of 8.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.98, marking an increase of 0.85.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 94.11 (Mar 24) to 0.00, marking a decrease of 94.11.
- For Price / BV (X), as of Mar 25, the value is 4.61. This value exceeds the healthy maximum of 3. It has increased from 3.35 (Mar 24) to 4.61, marking an increase of 1.26.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.98, marking an increase of 0.85.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Refex Industries Ltd:
- Net Profit Margin: 6.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.22% (Industry Average ROCE: 14.87%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15% (Industry Average ROE: 13.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.47
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.4 (Industry average Stock P/E: 281.98)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.16
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.41%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Industrial Gases | 2nd Floor, Refex Towers, Sterling Road Signal, 313, Valluvar Kottam High Road, Chennai (Madras) Tamil Nadu 600034 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Jain | Chairman & Managing Director |
| Mr. Dinesh Kumar Agarwal | WholeTime Director & CFO |
| Ms. Susmitha Siripurapu | Non Executive Director |
| Mr. Ramesh Dugar | Independent Director |
| Mr. Sivaramakrishnan Vasudevan | Independent Director |
| Ms. Latha Venkatesh | Independent Director |
| Dr. Vineet Kothari | Independent Director |
FAQ
What is the intrinsic value of Refex Industries Ltd?
Refex Industries Ltd's intrinsic value (as of 16 January 2026) is ₹297.92 which is 23.62% higher the current market price of ₹241.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,303 Cr. market cap, FY2025-2026 high/low of ₹534/212, reserves of ₹1,311 Cr, and liabilities of ₹1,793 Cr.
What is the Market Cap of Refex Industries Ltd?
The Market Cap of Refex Industries Ltd is 3,303 Cr..
What is the current Stock Price of Refex Industries Ltd as on 16 January 2026?
The current stock price of Refex Industries Ltd as on 16 January 2026 is ₹241.
What is the High / Low of Refex Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Refex Industries Ltd stocks is ₹534/212.
What is the Stock P/E of Refex Industries Ltd?
The Stock P/E of Refex Industries Ltd is 16.4.
What is the Book Value of Refex Industries Ltd?
The Book Value of Refex Industries Ltd is 103.
What is the Dividend Yield of Refex Industries Ltd?
The Dividend Yield of Refex Industries Ltd is 0.21 %.
What is the ROCE of Refex Industries Ltd?
The ROCE of Refex Industries Ltd is 25.3 %.
What is the ROE of Refex Industries Ltd?
The ROE of Refex Industries Ltd is 22.0 %.
What is the Face Value of Refex Industries Ltd?
The Face Value of Refex Industries Ltd is 2.00.